Analysis of Gene Transcription Changes Following Chlamydia pneumoniae Infection of THPl Monocytes May Have Relevance to Alzheimer\u27s Disease by Guthier, Desiré
Philadelphia College of Osteopathic Medicine
DigitalCommons@PCOM
PCOM Biomedical Studies Student Scholarship Student Dissertations, Theses and Papers
2019
Analysis of Gene Transcription Changes Following
Chlamydia pneumoniae Infection of THPl
Monocytes May Have Relevance to Alzheimer's
Disease
Desiré Guthier
Philadelphia College of Osteopathic Medicine
Follow this and additional works at: https://digitalcommons.pcom.edu/biomed
Part of the Neurology Commons
This Thesis is brought to you for free and open access by the Student Dissertations, Theses and Papers at DigitalCommons@PCOM. It has been
accepted for inclusion in PCOM Biomedical Studies Student Scholarship by an authorized administrator of DigitalCommons@PCOM. For more
information, please contact library@pcom.edu.
Recommended Citation
Guthier, Desiré, "Analysis of Gene Transcription Changes Following Chlamydia pneumoniae Infection of THPl Monocytes May Have
Relevance to Alzheimer's Disease" (2019). PCOM Biomedical Studies Student Scholarship. 174.
https://digitalcommons.pcom.edu/biomed/174
Philadelphia College of Osteopathic Medicine 
Graduate Program in Biomedical Sciences 
Department of Bio-Medical Sciences 
Analysis of Gene Transcription Changes Following 
Chlamydia pneumoniae Infection of THPl Monocytes 
may have relevance to Alzheimer's Disease 
A Thesis in Biomedical Sciences by 
Desire Guthier 
Submitted in Partial Fulfillment of the Requirements for the Degree of 
Master of Science in Biomedical Sciences 2019 
We, the undersigned, duly appointed committee have read and examined this manuscript 
and certify it is adequate in scope and quality as a thesis for this master's degree. We 
approve the content of the thesis to be submitted for processing and acceptance. 
Brian J. Balin, PhD. 
Director of the Center for Chronic Disorders of Aging, Chair of the Department of 
Biomedical Sciences, Professor of Neuroscience and Neuropathology 
Department of Bio-Medical Sciences 
Thesis Advisor 
Susan T. Ringley, PhD. 
Professor of Microbiology 
Department of Bio-Medical Sciences 
Thesis Committee Member 
Christopher Scott Little, PhD. 
Associate Professor of Microbiology and Immunology 
Department of Bio-Medical Sciences 
Thesis Committee Member 
Marcus G. Bell, PhD. 
Director of the Graduate Program in Biomedical Sciences, Professor of Neuroscience, 
Physiology and Pharmacology 
Department of Bio-Medical Sciences 
Program Director, Master of Science in Biomedical Sciences, Research Concentration 
iii 
ABSTRACT 
Analysis of Gene Transcription Changes Following Chlamydia pneumoniae Infection 
ofTHPl Monocytes may have relevance to Alzheimer's Disease 
Desire Guthier 
M.S. in Biomedical Sciences, 2019 
Dr. Brian J. Balin Ph.D., Thesis Advisor 
There is increasing evidence that neuroinflammation caused by infectious agents 
is an important etiologic factor in neurodegenerative diseases including Alzheimer's 
disease (AD). One infectious agent that has been associated with AD is Chlamydia 
pneumoniae (Cpn). Cpn DNA can be detected within peripherally circulating 
mononuclear cells and there is evidence that infected mononuclear cells could be 
involved in chronic infection and contribute to inflammation at numerous anatomical 
sites, including the brain. Understanding Cpn genetic changes progressing from an acute 
to a chronic infection within monocytes may help to further elucidate. the role of Cpn 
infected monocytes with regard to the neurodegeneration observed within AD. In this 
study, monocytes were infected in vitro with Cpn (either AR39 or CWL029) for 24, 48, 
72, 96, or 120 hours. Subsequently, we investigated transcriptional gene changes of 7 
Cpn genes using RT- PCR. We found a significant drop in gene expression at later time 
points in 3 of the genes. Our results demonstrate differences in gene expression from 
acute to chronic infection that perhaps indicate a trend towards persistence. However, our 
data does not unequivocally support that these gene changes are representative of the 
progression from acute to persistent infection. Future studies are required to resolve these 
differences and determine important gene changes that indicate persistent Cpn infection 
within monocytes. 
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INTRODUCTION 
Alzheimer's Disease (AD) is a neurodegenerative disorder that currently affects 
an estimated 5.8 million Americans (1). As the population of the U.S., age 65 and older, 
continues to increase, this number is expected to escalate to 14 million by 2050 (1). In 
2019, Americans will pay an estimated $290 billion on direct health care cost to care for 
those with AD and dementia (1). With statistics as stark as these, continued medical 
research into the etiology and pathogenesis of this disease is mandated. 
Symptomatology of AD occurs on a progressive timeline; the beginning stage 
often presents as an insidious onset of short-term memory loss, altered mood, behavior, 
and impaired higher cognitive function, while later stages of the disease progress to 
incapacitating memory loss, disorientation, and eventually death (2). There are two 
known forms of Alzheimer disease: the early onset familial form (FAD) which accounts 
for -5% of all AD cases and the late onset (LOAD) that accounts for the other -95% of 
AD cases (3) . FAD is a genetic disease characterized by various mutations in one or 
more of the following genes, the amyloid precursor protein gene (APP), presenilin 1 
gene, and the presenilin 2 gene (3). These mutations result in increased~- amyloid (A~) 
production and deposition extracellularly. A second defining neuropathological entity, 
the neurofibrillary tangles (NFTs ), accumulate intracellularly within damaged neurons. 
Together, the two pathologies are the hallmark of AD. Unlike Familial AD, LOAD is not 
a result of genetic mutation. Environmental and genetic risk factors for LOAD have been 
identified (3), however, very little is known about the specific etiology and pathogenesis 
of this fatal disease. 
There is controversy around the initiating factors of AD. One of the more widely 
accepted theories, coined the amyloid cascade hypothesis, involves the improper 
processing and cleavage of APP leading to AP production and deposition extracellularly 
(4). In both FAD and LOAD, Neurofibrillary tangles (NFTs) can accumulate 
intracellular!y within damaged neurons (2). NFTs are made of the misfolded and 
hyperphosphorylated protein tau, a microtubule associated protein functioning normally 
as a structural and transport protein within the nerve cell. In the diseased state, the cell 
structure collapses and tau can no longer assist with the microtubule transportation of 
nutrients and neurotransmitters (2). 
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For the past two decades, AP plaques have been thought to initiate the 
pathological process of AD and be a significant contributor to neurotoxicity (5). 
However, this theory has been disputed for a number of reasons. For one, concentrations 
of plaques in the AD brain are in the picomolar range but given the amount of 
neurotoxicity displayed, the plaque concentrations would be expected to be a million 
times more concentrated in the micromolar range ( 6). Secondly, studies have shown 
through histochemical and immunocytochemical analyses, that numerous patients with 
AP amyloid deposition, examined postmortem, did not have symptoms of AD (7). This 
suggests that AP deposition may not necessarily be responsible for cognitive decline (7). 
Further, AP peptides may have neuroprotective effects by functioning as antimicrobial 
anionic defensive peptides (8). One more reason for disputing the amyloid hypothesis is 
clinical trial failures (9). Disease modifying drugs developed thus far have included drugs 
to reduce AP production, prevent AP aggregation, and drugs to promote AP clearance 
which have all demonstrated no efficacy and have failed phase III clinical trails (9). 
Therefore, many questions remain unanswered about the true etiology and pathogenesis 
of LOAD, and as such, consideration of other evidence is warranted. 
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Inflammation in the brain in LOAD is a contributing factor to the neuropathology 
observed in AD. Activated microglia that respond to A~ deposition and/or other insults 
may initiate and propagate an inflanunatory response (6). Without complete clearance of 
the initiating stimuli, the cascade of neuroinflanunation and neuropathology may be 
chronic (6). To date, clinical trials using NSAIDS as a method for treatment have proved 
ultimately unsuccessful (10). There has been some evidence to suggest that continued use 
ofNSAIDs can delay onset of symptoms, but once cognitive dysfunction becomes 
apparent NSAIDs seem to have no effect (10-12). 
Interestingly, another stimulus for neuroinflanunation in AD may be infection (3, 
13, 14). An infectious etiology for many chronic diseases, including AD, is not a foreign 
concept and has long been debated. Although infectious etiology of LOAD is not the 
standard dogma in the AD scientific conununity, there are many researchers around the 
world looking at infections as possible causative agents of LOAD. Prime examples of 
infectious agents being studied as potential pathologic causes of LOAD are Spirochetes 
(15), Herpes Simplex Virus 1(16, 17) and Chlamydia pneumoniae (Cpn) (3, 13, 14). Cpn 
is a very interesting potential etiologic agent of AD, and is the focus of this research 
study. 
There is strong evidence to suggest a potential causal relationship between Cpn 
and LOAD. The first study correlating Cpn to AD was published in 1998 (18). The study 
looked at brain tissue samples from post- mortem LOAD patients as well as control brain 
tissue samples and used PCR with probes specific to Cpn DNA ( 18). Interestingly, 90% 
of the postmortem brain tissues from AD patients were infected with Cpn in areas of the 
brain that usually exhibit AD pathology (18). This was compared to the control post-
mortem brain tissue samples where only 5% of the brain tissue samples were determined 
to be infected with Cpn (18). The presence of Cpn in the AD brain the study used 
immunohistochemistry and electron microscopy techniques and results correlated with 
their initial PCR findings (18). The 1998 study also observed an interesting connection 
between ApoE e4 allele and Cpn, a noted risk factor for AD. Eleven out of the 19 cases 
that were infected with Cpn in the LOAD brain also had at least one ApoE E4 allele (18). 
Additional evidence was obtained when non-transgenic BALB/c mice were intranasally 
infected with Cpn; A~ deposits similar to plaques found in AD brains were found within 
tbe infected brains of the mice in areas typically affected in AD (19, 20}. 
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Cpn is an obligate intracellular bacterium and is a pervasive respiratory pathogen 
(21 ). The acute infection witb Cpn has a distinct developmental cycle that alternates 
between two morphological forms; the metabolically inactive and infectious form termed 
the elementary body (EB) and the metabolically active form responsible for repeated 
binary fission termed the reticulate body (RB) (21). After endocytic host cell entry, the 
EB converts to its metabolically active RB form and a specialized vacuole or inclusion 
body encapsulates the dividing bacteria (22). The RB are able to efficiently acquire 
nutrients from the host for fast replication and other metabolic activities within the host 
cell but are also not infectious and less stable than EBs at this point in their life cycle 
(23). The infection modifies host cell lysosomal pathways preventing lysosomal fusion 
with the vacuole, and the organism continues to multiply prior to conversion back to EBs 
for release from the cell and dissemination. 
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Cpn is airborne and is transmitted through respiratory droplets from person to 
person (24). Cpn is an etiologic agent for community acquired pneumonia and bronchitis 
(24) but has also been shown to disseminate throughout the body and may lead to 
exacerbation of atherosclerosis and possible involvement in AD etiology (18, 25). 
Furthermore, Cpn infection has also been associated with asthma (26), lung cancer (27), 
arthritis (28), chronic obstructive pulmonary disease (29), and diabetes (30). Potential 
modes of Cpn dissemination throughout the body have not been completely elucidated 
but there is strong evidence to suggest that the organism can move from the respiratory 
tract by a number of mechanisms. First Cpn can infect monocytes in the lung tissues and 
can travel systemically to many regions of the body (31). Of particular interest relating to 
AD, Cpn may enter the brain through the blood-brain barrier following infection of 
monocytes. Research has shown that Cpn infected monocytes can mitigate trans-
endothelial entry through human brain microvascular endothelial cells (HBMECs) by up-
regulation ofVCAM-1 and ICAM-1 on HBMECs and increasing LFA-1, VLA-4, and 
MAC-1 on infected monocytes (31 ). This is an important discovery providing evidence 
on how Cpn could invade the brain to eventually promote inflammation characteristic of 
AD (31). 
Another possible route for Cpn entry into the CNS is through the olfactory 
system. Since Cpn is a respiratory pathogen, it has ready access to olfactory 
neuroepithelium of the nasal olfactory system. Upon infection of these cells, the 
organisms could migrate to the olfactory bulbs and then to deeper areas of the brain such 
as the entorhinal cortex and hippocampus (32). Interestingly, an impaired sense of smell 
and olfactory dysfunction has been noted as an early dysfunction in AD (33). 
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Cpn has been reported to enter a chronic infectious state leading to persistence 
characterized by a long-term relationship between bacteria and infected host cells, 
including monocytes/macrophages (22). Cpn persistent infection is characterized by 
visualization through electron microscopy of enlarged, morphologically aberrant RBs that 
do not mature into infectious EBs (34, 35). Persistent infection may cause 
pathophysiology in chlamydia! related diseases including AD (14, 36). For this reason, it 
is important to investigate causes of persistence and changes in Cpn gene expression 
during persistence to further understand host interaction. Cpn entering the persistent state 
as a response to stress is the current paradigm (36). Studies have been performed in 
which Cpn was driven into a persistent infection following exposure to antibiotics, 
interferon-y (IFN-y), and iron starvation(22, 37, 38) Intriguingly, current research 
suggests that Cpn persistence also may be a mechanism by which evasion of the host 
immune response through alternative metabolic pathways may occur (36). 
As previously stated, although a specific etiology of LOAD pathogenesis has not 
been defined, evidence surrounding inflammation as a central contributing factor of 
LOAD pathology has been strongly suggested (39-42). In this regard, Cpn's ability to 
maintain a chronic infection within monocytes has been shown to induce an 
inflammatory cascade (43). Cpn infection ofmonocytes in vitro has been shown to result 
in significant cytokine production including that ofIL-1~, IL-6, and IL-8 (43). Thus if, 
Cpn infected monocytes cross the blood brain barrier, they have the potential to produce 
a significant inflammatory response that could lead to pathology seen in AD. How Cpn 
infection becomes chronic and/or persistent in monocytes to modulate the host immune 
response has not been fully elucidated. Genome wide Cpn analyses have been performed 
within epithelial cells during an acute and induced persistent state to further understand 
Cpn and host interactions (22, 35, 44). Very few studies have looked at Cpn gene 
transcription within infected monocytes/ macrophages (34, 45). 
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Although Cpn Gene expression within monocytes is not well understood, it is 
crucial to the understanding of disease pathogenesis in which chronic or persistent 
infection is evident. Given the limited gene transcription analysis that has been performed 
within monocytes (22, 35, 44, 45), we examined the following Cpn genes; euo, 129, abcX, 
ttif, hctA, lctH, and J 6S (see table 1) within two different Cpn respiratory strains (AR39 
and CWL029) to better understand Cpn gene expression following infection of human 
THPl monocytes over a time course of24-120 hours post infection (hpi). 
Two corurnon Cpn respiratory strains were chosen because it has been discovered 
that there are genetic differences between AR39 and CWL029, specifically 16111165 
proteins are not identical ( 46). Most importantly, there is a plasmid that is present in 
AR39 but not in CWL029 ( 46). For this reason, we wanted to determine if there is a 
difference in gene expression between AR39 and CWL029 following infection of 
monocytes. In addition, Cpn strains AR39 and CWL029 strains have been shown to be 
most closely related to the Cpn strains found in the AD brain and have also been shown 
to cause A~ deposits similar to plaques in AD brains in mice (20). 
-- -- - - - . 
hctA. Hisfone"likeptoteih . 
lcrH Chaperoneprotein within the T3SS 
tuf ·· · Elongation fact()r 
16S . Cpn Ribosmnal protein 
euo · Early upstream ORF 
129 50S ribosomal protein 
abcX ABC transporter ATPase 
Late cycle ,_, 36 hpi (4'7) · 
Late in cycle ( 4 7) 
Mid- late cycle ( 48) 
Expressed throughout 
entire 1ifecycle 
· Ilatly iii cycfo (49) 
Expressed throughout 
entire lifecycle (47) 
Expressed.throughout 
. entire lifecycle (4 7) .· 
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Table 1 Cpn genes examined and life cycle expression of those genes. In our study we 
examined the Cpn genes listed in the above table. These genes were chosen based on 
previous research showing evidence that these particular genes were expressed at variable 
time points in the Cpn life cycle (22). Gene expression profiles for Cpn have been 
previously defined in clusters. These clusters are defined by genes that are active at the 
same time in the life cycle: acute (24-48 hpi) and chronic (72-120 hpi) (22). We adopted 
this model in our study in order to further classify and choose genes of interest. In 
addition, each of these genes has shown to change its expression in a persistent state 
within an epithelial cell line (22). 
1.1 Hypothesis 
There will be gene transcriptional changes of Cpn following infection of human THPl 
monocytes over a 120-hour time course that will reflect the evolution of an acute 
infection to that of a chronic infection independent of the Cpn strain (AR39 and 
CWL029) used for the infection. 
1.2 Specific Aims 
1. To analyze the percent of Cpn infected THPl after 24, 48, 72, 96, and 120 hours 
post infection (hpi) with AR39 and CWL029 strains using immunofluorescent 
labeling techniques. 
2. To evaluate changes of gene expression between acute (24-48 hpi) and chronic 
(72-120 hpi) stages ofCpn infection ofTHPl monocytes in two strains ofCpn 
infection strain (AR39 and CWL029). 
3. To determine ifthere is a difference in gene expression between AR39 and 
CWL029 infection strains over 24-120 hours post infection. 
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METHODS 
2.1 THPl Human Monocytes 
THP 1 monocytes were grown and maintained at lxl 06 cells/ml in RPMI growth 
media (GM) supplemented with heat activated 10% Fetal Bovine serum in an incubator at 
37 ·c and 5% C02. 
2.2 Infection with Cpn 
THPl cells were centrifuged, washed with Hank's Balanced Salt Solution 
(HBSS), and then re-suspended at a concentration of lxl06 cells/ mL in lmL of GM. One 
of the two strains of human respiratory Cpn, AR39 or CWL029, were used to infect 
THPl cells at Multiplicity oflnfection (MOI) of 1. Cells were incubated at 37"C and 5% 
C02 for one hour in a T25 flask. GM was then added to the infected cells to bring the 
total volume of the flask up to lOmL. Cells were then incubated at 37"C and 5% C02 and 
infected THP 1 monocytes were extracted at 5 different time points: 24, 48, 72, 96 and 
120 hours. Control experiments for all infected time points were performed with 1x106 
uninfected cells suspended in 10 mL of GM. 
At the time of extraction for both infected samples and controls, T25 flasks were 
removed from the incubator and their contents were transferred into 25 mL tubes. The 25 
mL tubes were centrifuged at 500 x g for 5 min. Supernatants were removed and pellets 
were washed with HBSS. Cell concentration was then determined using a hemocytometer 
and cell pellets consisting of lxl 06 cells were frozen at -60 "C until RNA extraction was 
performed for RT-PCR. 
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2.3 RNA Isolation 
RNA was purified according to the manufacturer's instructions using a RN easy 
isolation kit (Qiagen RN easy). Frozen pellets were thawed and centrifuged for 5 min at 
300 x g. Pellets contained lxl 06 cells for each sample. RL T (350 µI) was added to each 
sample to disrupt cells. This entire mixture was then pipetted into a QIAshredder placed 
in a 2ml collection tube. Sample was then centrifuged for 2 min at 20,000 x g to lyse 
cells. The QIAshredder was discarded and flow through in the collection tube was 
saved. 70% ethanol (350 µI) was added to the sample and mixed well. The entire volume 
was then transferred into a RN easy spin column in 2 ml collection tube and centrifuged 
for l 5s at 8000 x g. The flow through and collection tube were discarded and the RN easy 
spin column was placed above a new collection tube. Buffer RWI (350 µl) was added to 
the RNeasy spin column with collection tube and centrifuged for 15s at 8000 x g to wash 
the spin column membrane. Flow through was discarded and the RNeasy spin column 
was transferred into a new collection tube. DNase stock solution I (10 µl) was added to 
Buffer RDD (70 µl) and mixed thoroughly. DNase I incubation mix (80 µl) was added to 
RNeasy spin column membrane and the mixture was allowed to sit for 15 min to digest 
DNA. Buffer RWl (350 µl) was added to the RNeasy spin column with collection tube 
and centrifuged for 15 sec at 8000 x g. Buffer RPE (500 µI) was added to the RNeasy 
spin column and centrifuged for 2 min at 8000 x g in order to wash the spin column 
membrane and dry any residual ethanol. The RN easy spin column was then placed in a 
new collection tube and spun for 1 min at 20,000 x g to dispose of any carry over Buffer 
RPE. Flow through and collection tube were discarded. The RN easy spin column was 
placed over a \ .5 ml collection tube. RNase free water (30 µI) was added to the RN easy 
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spin column and centrifuged for I min at 8000 x g. This step was then repeated for a total 
of 60 µl of eluted RNA in RNase free water. Samples were frozen and stored at -60 "C 
until RNA was used for RT-PCR. 
After RNA isolation was perfo1med, overall RNA concentration was determined 
from its optical density at 260 nm by using UV Spectrophotometry. Other measurements 
recorded included purity values: A,,J A,,. and A,,J A, •. 
2.4 First Strand Synthesis 
Reverse transcription reaction was performed using RETROscript Kit (Applied 
Biosystems) following manufacturer's protocol. RNA (500 ng) was mixed with 2 µl of 
Random Decamers; nuclease-free water was added to this mixture to total 12 µI. The 
mixture was then centrifuged briefly and heated for 3 min at 85 "C in order to denature 
RNA. Each sample was briefly centrifuged and placed on ice. Two µl of !Ox RT buffer, 4 
µl of dNTP mix, and 1 µI ofRNase inhibitor was added to the denatured RNA sample. 
Samples were mixed thoroughly, centrifuged briefly, and incubated for 1 hour at 55 "C. 
Sample were then incubated for 10 min at 92 "C to inactivate the reverse transcriptase. 
Samples were then frozen and stored at -80 "C until cDNA was used for RT-PCR. 
2.5 Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) 
qRT- PCR was used to determine the relative level of gene transcription for the 
following genes: euo, 129, abcX, tuf, hctA, lctH, Human I BS rRNA and chlamydia! J 6S. 
qRT-PCR was run following manufacturer's protocol (Taqman Gene Expression Assay-
Applied Biosystems) on Cpn infected THP 1 monocytes and their uninfected controls for 
cDNA and DNA at 24, 48, 72, 96 and 120 hrs. For DNA samples, 10 µI of Master Mix, I 
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µl of Primer, 250 ng of DNA, and DNase free water to equal 20 µl was added to each 
well of the 96- well plate. For cDNA samples 10 µl of Master Mix, 1 µl of Primer, 2 µl 
of cDNA, and DNase free water to equal 20 µl was added to each well of the 96- well 
plate. The qRT- PCR plate was run and analyzed using Applied Biosystems StepOne and 
StepOne plus Real-Time PCR systems. Expression of Cpn genes was normalized using 
human 18S rRNA as an endogenous control. 
2.6 Immunofluoresceuce 
Cpn labeling was visualized at 24, 48, 72, 96, and 120 hpi for both AR39 and 
CWL029 strains of Cpn. Cells at lxl05 were suspended in 400µ1 ofHBSS and pipetted 
into Shandon single Cytology Funnels (Fischer Scientific, Pittsburg, PA) with inse1ied 
Superfrost Slides (Fischer Scientific). Cytology Funnels containing slides and sample 
were centrifuged for 5 min at 500 rpm, medium acceleration, using a Shandon Cytospin 
III Cytocentrifuge. Cells were fixed onto slides with BD Cytofix/ Cytoperm for 30 mins, 
and washed with PBS at room temperature and immunolabeled with Cpn specific 
antibody (FITC directly tagged antibody 61C75, ThermoFischer) at 37°C for one hr. 
Slides were washed with filtered water and mounted with Flouro-gel II Mounting 
medium with DAPI and coverslips. Slides were stored at 4°C without light until 
visualization. 
Samples were viewed using a Nikon Eclipse 80i microscope 40x Nikon Plan 
Flour 40x/0.75 OFN25 DIC M/N2 objective. For each slide, 10 fields were captured 
using Nikon DS- Ri 1 Camera and NIS- Elements Advanced Research Software version 
3.0 (Nikon). For each field captured, total cell counts and Cpn-infected cell counts were 
documented. Criteria for positive cell count required visualization of tlnee or more 
punctate bodies or 1 large inclusion. Percentage of infected cells were determined from 
these counts at each time point. Experiments were performed in triplicate and counts 
were averaged for statistical significance. 
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RESULTS 
3.1 Qualitative evaluation of Cpn infection using immunofluorescent microscopy 
Cultures ofTHPl monocytes infected with Cpn strains CWL029 andAR39 for 
24, 48, 72, 96, or 120 hrs were evaluated for percent infectivity using immunofluorescent 
microscopy analysis. Figure I shows representative micrographs of AR39 infected THPl 
monocytes at 24, 48, 72, 96, and 120 hours post-infection (hpi) and uninfected control 
cells. The percent infected at 24, 48, 72, 96, and 120 hpi were 52.4 ± 1.0%, 47.0 ± 1.8%, 
53.9 ± 4.0%, 46.6 ± 2.8, and 48.3 ± 4.1 %, respectively (see table 2). The uninfected 
THP 1 monocytes showed 0% infectivity for all time points. Figure 2 shows 
representative micrographs ofCWL029 infected THPl monocytes at 24, 48, 72, 96, and 
120 hpi and uninfected control groups. The percentage of cells infected at 24, 48, 72, 96 
and 120 hpi were 41.3% ± 1.7, 45.0% ± 4.5, 55.6% ± 4.7, 61.8% ± 4.7, and 62.7 ± 2.6%, 
respectively (see table 3). The uninfected THPl monocytes showed 0% infectivity for all 
time points. 
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Figure 1. Immuuofluorescent labeling of AR39 Infected THPl Monocytes. 
At all-time points, 24-120 hours uninfected cells were immunolabeled for Cpn and shown 
to be negative for infection (representative micrograph, A). THP 1 Monocytes infected for 
24, 48, 72, 96, and 120 hpi demonstrated Cpn (green) respectively (B-F). Cell nuclei in 
all micrographs were labeled with DAPI (blue). Original magnification (400x). 
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Figure 2. Immuuofluorescent labeling of CWL029 Infected THPl Monocytes. At all 
time points, 24-120 hours uninfected cells were immunolabeled for Cpn and shown to be 
negative for infection (representative micrograph, A). THPl Monocytes infected for 24, 
48, 72, 96, and 120 hpi demonstrated Cpn (green) respectively (B-F). Cell nuclei in all 
micrographs were labeled with DAPI (blue). Original magnification (400x). 
3.1.1 Determining percent infectivity using immunofluorescent labeling 
AR39 Biological Total# of Total# of Percent Percent 
Replicates Cells Cells Infected Totals 
Positive Counted 
Experiment I 60 113 53.1 
-24 bpi Experiment 2 60 125 51.2 52.4 ± 1.0 
Experiment 3 54 102 52.9 
Experiment I 56 124 45.2 
48 hpi Experiment 2 62 127 48.8 47.0 ± 1.8 
Experiment 3 56 119 47.l 
Experiment 1 55 105 52.4 
72 hpi Experiment 2 95 187 50.8 53.9 ±4.0 
Experiment 3 122 209 58.4 
Exoeriment 1 56 129 43.3 
96 hpi Experiment 2 84 174 48.3 46.6 ±2.8 
Exoeriment 3 102 212 48.l 
Experiment 1 49 96 51.0 
120 hpi Exoeriment 2 89 177 50.3 48.3 ± 4.1 
Experiment 3 80 184 43.5 
Table 2. Percent infectivity using immnnoflnorescent labeling of AR39 infected 
THPl monocytes. 
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At all-time points, 24-120 hours uninfected cells were immnnolabeled for Cpn and shown 
to be negative for infection (cell counts not shown). THPl monocytes infected for 24-120 
hpi were immunolabeled for Cpn. For each experiment, 10 fields were captured using 
Nikon DS- Ril Camera and NIS- Elements Advanced Research Software version 3.0 
(Nikon). Criteria for positive cell count required visualization of three or more punctate 
bodies or 1 large inclusion. 
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CWL029 Biological Number of Total cells Percent Percent 
Replicates Cells Counted Infected Totals 
Positive 
Experiment 1 50 124 40.3 
24 bpi Experiment 2 56 139 40.3 41.3 ± 1.7 
Experiment 3 77 178 43.3 
Experiment 1 59 121 48.8 
48bpi Experiment 2 97 210 46.2 45.0±4.5 
Experiment 3 69 172 40.l 
Experiment 1 83 160 51.9 
72 bpi Experiment 2 72 133 54.1 55.6±4.7 
Experiment 3 98 161 60.9 
Experiment 1 81 121 66.9 
96 bpi Experiment 2 99 172 57.6 61.8 ± 4.7 
Experiment 3 178 292 61 
Experiment 1 125 198 63.1 
120 bpi Experiment 2 102 157 65 62.7 ± 2.6 
Experiment 3 91 152 59.9 
Table 3. Percent infectivity using immunofluorescent labeling of CWL029 infected 
THPl monocytes. 
At all-time points, 24-120 hours uninfected cells were immunolabeled for Cpn and shown 
to be negative for infection (cell counts not shown). THPl monocytes infected for 24-120 
hpi were immunolabeled for Cpn. For each experiment, 10 fields were captured using 
Nikon DS- Ril Camera and NIS- Elements Advanced Research Software version 3.0 
(Nikon). Criteria for positive cell count required visualization of three or more punctate 
bodies or 1 large inclusion. 
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3.2 Cpn gene expression in human monocytes 
We analyzed the transcription of 7 Cpn genes expressed by two different strains 
(AR39 and CWL029) of Cpn in THP 1 monocytes. Cells were lysed and RNA was 
extracted at 24, 48, 72, 96, and 120 bpi. Amplification of RNA from uninfected 
monocytes was included as negative control. Forty-eight bpi was used as a reference time 
point and JBS rRNA was used as a human housekeeping gene to normalize transcription 
levels. RT reaction used cDNA, which was then used in RT-PCR. Relative quantities of 
transcribed genes were obtained using qRT-PCR. All genes were evaluated in triplicate 
per PCR plate and each gene was amplified on multiple PCR plates. 
3.3 Normalization of Cpn gene transcription 
Human JBS rRNA was used to normalize the Cpn transcription data. We initially 
used chlamydia! J 6S rRNA to normalize chlamydia! expression as numerous published 
articles have used this gene as a housekeeper gene (22, 44, 50). However, during our 
study we found that although J 6S was stably expressed at each time point, there was 
variability between the time points. Human JBS rRNA was the most stably expressed 
gene we analyzed as the CT value for the expression was consistent regardless of time 
point. This allowed us to compare Cpn expression levels to total gene expression iu the 
cell making it the best candidate for a control in our experiments. 
3.4 Cpn genes evaluated for transcriptional change 
Expression of hctA of Cpn for strain AR39 had a 2.6 fold increase from 24 to 48 
bpi. Gene expression continued to increase and peaked at 72 hours. A 3.5 fold decrease 
21 
gene expression was observed from 72 to 96 hpi and remained low at 120 hpi. The same 
gene in the CWL029 strain showed no difference (Figure 3). 
Cpn lcrH transcription levels for strain AR39 were elevated at 72 hpi in 
comparison to the other time points. A 2.4 fold increase from 48 hpi to 72 hpi is seen in 
the AR39 Cpn strain. In contrast, CWL029 lcrH transcription levels decreased by 2.3 fold 
from 48 hpi to 72 hpi. Both strains showed transcription levels decreasing at 96 hpi and 
120 hpi. AR39 lcrH transcription levels decreased 6.5 fold from 48 hpi to 72 hpi. 
CWL029 lcrH transcription levels decreased 1.8 fold from 48 hpi to 72 hpi (Figure 4). 
Our data for Cpn AR39 tuf gene expression showed highest transcriptional levels 
at 24 hpi by 3 .24 fold when compared to 48 hpi. Decreased levels of transcription by 3 .9 
fold were observed at both 96 hpi and 120 hpi when compared to 48 hpi. Cpn CWL029 
had much lower transcriptional levels at almost every time point, although, a similar 
pattern to the AR39 strain was observed for 48-120 hpi (Figure 5). 
Cpn AR39 I 6S rRNA expression interestingly shows transcription levels are 2.4 
fold higher at 24 hpi and 1. 7 fold higher at 72 hpi when compared to 48 hpi. 
Transcription levels then decrease by 1.16 fold at 96 hpi when compared to 48 hpi. 
Transcription levels of I 6S rRNA for Cpn CWL029 were lower at 24, 72, 96 and 120 hpi 
when compared to 48 hpi. Transcription levels were decreased by 3.2 fold and 5.4 fold at 
96 hpi and 120 hpi, respectively when compared to 48 hpi (Figure 6). 
Data for euo, /29 and abcX gene expression also was collected for both strains, 
however standard deviations were too high to make any conclusions (raw data in 
appendix). 
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hctA gene expression for Cpn strain AR39 
•AR39 
24 hpi 48 hpi 72 hp1 96 hpi 120 hpi 
Hours Post Infection (hpi) 
Figure 3. Analysis of hctA gene expression of Cpn strain AR39 following infection of 
THP 1 Human Monocytes. Cells were infected (MOI 1, n=12) with Cpn and relative 
expression of hctA was quantified at 24, 48, 72, 96, and 120 hpi. 48 hpi was used as a 
reference time point and I BS was used as an endogenous control. Data for the CWL029 
strain was collected but not shown as there was not a change at any time point. n=number 
of technical replicates from same sample. Error bars represent standard deviations. 
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lcrH gene expression for Cpn strain AR39 vs CWL029 
25 
I AR39 
• CWL029 
0.5 II I •• 0 • 24 hpi 48 hp\ 72 hp1 120 t1pi 
Hours Post Infection (hpi) 
Figure 4. Comparative analysis of lcrH gene expression following infection of THP 1 
Human Monocytes with two different Cpn strains AR39 and CWL029. Cells were 
infected separately (MOI 1) with Cpn (AR39, n=9 and CWL029, n=6) with Cpn and 
relative expression of lcrH was quantified at 24, 48, 72, 96, and 120 hpi. 48 hpi was used 
as a reference time point and 1 BS was used as an endogenous control. n= number of 
technical replicates from same sample. Error bars represent standard deviations. 
24 
tuf gene expression for Cpn strain AR39 vs CWL029 
6 
• AR39 
• CWL029 
0 • II I. -- ·~· 24 hp1 43 hpj 72 hpl 96 hµ1 120 hpl 
Hours Post 1nrection (ii pi} 
Figure 5. Comparative analysis of tuf gene expression following infection of THP 1 
Human Monocytes with two different Cpn strains AR39 and CWL029. Cells were 
infected separately (MOI 1) with Cpn (AR39, n= 6 and CWL029, n=6) with Cpn and 
relative expression of tuf was quantified at 24, 48, 72, 96, and 120 hpi. 48 hpi was used as 
a reference time point and I SS was used as an endogenous control. n= number of 
technical replicates from same sample. Error bars represent standard deviations. 
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165 gene expression for Cpn strain AR39 vs CWL029 
3 5 
•Af:H9 
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0.5 
• II I -· 0 24 hpi qg hpi 72 hp"1 95 hpi 120 hpi 
Hours Post Jnfection (hpj) 
Figure 6. Comparative analysis of 16S gene expression following infection of THP 1 
Human Monocytes with two different Cpn strains AR39 and CWL029. Cells were 
infected separately (MOI 1) with Cpn (AR39, n=15 and CWL029, n=12) with Cpn and 
relative expression of lcrH was quantified at 24, 48, 72, 96, and 120 hpi. 48 hpi was used 
as a reference time point and 1 BS was used as an endogenous control. n= number of 
technical replicates from same sample. Error bars represent standard deviations. 
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DISCUSSION 
Previous studies have identified and analyzed transcriptional changes during the 
developmental life cycle of Cpn during acute infection (22, 51, 52). Genome wide 
transcriptional analyses have mostly been reported within epithelial cell lines (22, 35, 
44 ), and while these studies have been monumentally important in understanding the life 
cycle of Cpn, changes in gene expression within white blood cells is essential for a more 
complete understanding of disease pathogenesis of AD. The monocyte is an important 
link between acute and chronic infection with Cpn because of Cpns ability to maintain a 
persistent state within the cell and cause the host cell to elicit a chronic inflammatory 
response ( 43). In this regard, only a few studies have explored transcriptional gene 
changes within monocytes (34, 45). In the current study, we have explored transcriptional 
changes of Cpn within THP 1 monocytes in vitro to determine how gene changes are 
regulated in a temporal pattern as the infection progresses. 
Cpn replicates within a eukaryotic host cell in a unique developmental cycle 
marked by EB and RB. The lifecycle of Cpn is marked by temporal genes that are 
expressed during early, mid and late stages of the life cycle and in times of stress enter 
into a persistent state (22). In the current study, we have evaluated the transcriptional 
levels ofCpn genes at different time points of the Cpn lifecycle. For example, hctA is a 
gene for Histone Hl like protein with homology to eukaryotic histone protein (54). HctA 
has been proposed to be essential for differentiation from RB back to EB (55). During 
acute infection, the gene is expressed in the late phase of the acute life cycle; previous 
studies have shown increased transcriptional activity at 36 hpi during a 48 hour Cpn 
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lifecycle (22). Expression of this histone like protein represses ftnther transcription and 
translation of the chlamydia! genome (54, 56). In our study, following infection with the 
AR39 strain of Cpn, the relative quantity of hctA more than doubled from 24 to 48 hours 
and gene expression peaked at 72 hpi. These results are consistent with previous studies 
showing increased expression in late phase of the life cycle. Unexpectedly, we found that 
at 96 hpi and 120 hpi there was a significant drop in gene expression of hctA. Decreased 
expression of hctA could possibly represent a trend towards persistence in monocytes. 
However, previous studies have demonstrated conflicting data for expression of hctA 
during persistence. One study demonstrated that depletion of iron lead to persistence and 
hctA gene expression was unaltered during this state (22). In contrast, two studies 
demonstrated that during penicillin induced persistence, down regulation of hctA 
expression occurred ( 44, 57). Further, IFN-y models of persistence have shown both up 
regulation of hctA (44) as well as down regulation of hctA (36). Variations in expression 
of this gene could possibly be explained by the different conditions promoting persistence 
in these models, however this correlation remains to be clarified. 
Cpn gene analysis demonstrated that at 96 hpi and 120 hpi, the tuf gene was 
downregulated significantly when compared to earlier time points. Tuf is a gene that 
transcribes for an elongation factor that is highly conserved among eubacteria (58). Tuf 
has been shown to be expressed during mid and late cycle with complex regulation (48). 
Interestingly, this gene has also been used in previous studies as a housekeeping gene 
following infection of epithelial cells (22). In our study we saw a drop-in gene expression 
over time. Down regulation of tu[ at later time points could indicate a decrease in 
translational activity and potentially indicate a trend toward Cpn persistence within 
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monocytes. Confirmation of this persistence could be obtained upon visualizing 
persistent aberrant bodies with ultrastructural analysis, which unfortunately was outside 
the scope of the current study. Also, it would be interesting to see if similar results would 
be obtained upon inducing persistence with methods such as exposure to IFN-y or iron 
depletion. 
Surprisingly, we found differences in gene expression between Cpn strains AR39 
and CWL029. When evaluating AR39 at 72 hpi, lcrHhad increased expression from 48 
hpi. When evaluating CWL029 there was a decrease in gene expression from 48 hpi. 
LcrH is a gene that expresses a chaperone protein within the Cpn Type III secretion 
system (T3SS), an important virulence factor that allows interaction between bacterium 
and host. Bacteria use T3SS to inject proteins into the host cell cytosol changing the 
environment in favor of bacterial survival (59). This could suggest that there may be 
strain differences in expression of the T3SS. Since the T3SS changes the environment of 
the host cytosol, differences in gene expression could potentially alter the expression of 
multiple proteins. 
Interestingly, with both the CWL029 and AR39 Cpn strains there was down 
regulation in the lcrH gene expression at 96, and 120 hpi. These findings are consistent 
with previous studies, which have shown decrease in lcrH gene expression during 
persistent infections. IFN-y mediated persistence as well as iron depletion mediated 
persistence has demonstrated down regulation of gene expression (22, 44, 60). Although 
we are not able to specifically detennine persistence in our study, decreased transcription 
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of lcrH during later timer points is interesting as it is consistent with downregulation of 
gene transcription in iron depletion of Cpn which leads to persistence (22). 
One interesting finding that we discovered is that Cpn l 6S was not the best 
housekeeping gene for normalization, although, several previous studies normalized Cpn 
gene expression to Cpn J 6S (22, 44, 50). However, another study found similar results to 
ours in that l 6S rRNA produced higher standard deviations compared to other 
housekeeping genes (22). Subsequently, we found that THPl eukaryotic I BS was the 
most stably expressed housekeeping gene in our study. This raises an important question 
on choosing the best gene candidates for PCR normalization in any given experimental 
design, and whether or not J 6S should be used routinely as a housekeeping gene. 
Cpn immunofluorescent data for the AR39 strain showed approximately 46-53% 
percent infectivity at 24-120 hpi. Cpn immunofluorescent data for the CWL029 strain 
showed approximately 41-62% percent infectivity at 24-120 hpi. We infected THPl 
monocytes at an MOI= 1. However, multiple infectious units were present within THPl 
monocytes and no infectious units were present in other cells. We believe that the same 
number of infectious units were present in our experiment but did not infect the cells in a 
1:1 ratio. Overall the infectivity of the THPl monocytes stayed relatively uniform from 
24-120 hpi for both Cpn strain AR39 and CWL029. Our infection was maintained at the 
same percent infectivity throughout 24 hpi-120 hpi and there was overall decrease in 
gene transcription of the Cpn genes evalutated. This could potentially indicate a trend 
toward a persistent infection since the infection is being maintained through 120 hpi at 
around the same percent infectivity as the early time points and transcriptional levels are 
decreasing. However, it is nnclear weather or not the infection we are visualizing at the 
chronic time points (after 48 hpi) could also represent a recycling of an acute infection. 
These results would need to be confirmed with visualization on electron microscopy of 
Cpn abberant bodies. 
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Some potential limitations to our study should be noted. There was only one 
biological replicate used for each strain of Cpn. All other replicates were technical 
replicates. Although there was a sample size of 6 or more per gene per time point studied, 
in order to increase the statistical significance, the study should be replicated with 
biological experimental replicates. In addition, we did not induce persistence with a 
model such as exposing the bacteria to IFN-y. Having this data in comparison to the acute 
infection to compare and contrast would strengthen our findings. In addition, in future 
studies it would be important to visualize the organism within monocytes with electron 
microscopy and compare this to the genetic data. This information would help us 
determine a trend toward persistence, if we were able to visualize aberrant bodies. 
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4.1 Conclusions 
In conclusion, our study helps contribute to the overall understanding of how Cpn 
interacts with its host. We still have a lot to learn about its interplay and only few studies 
have evaluated Cpn gene expression within a monocyte cell line (34, 45), a crucial 
component to the development of Cpn persistent infection and pathogenesis of AD. The 
purpose of this study was to investigate transcriptional gene changes of Cpn following 
infection of human THP I monocytes over a 120-hour time course to evaluate potential 
evolution of an acute infection to that of a chronic infection. Our research demonstrates 
certain gene changes that are suggestive of progression towards chronic and perhaps 
persistent infection. In order to validate these findings, visualization of enlarged, 
morphologically aberrant Cpn bodies through ultrastructural analysis is needed. In 
addition, we would need more replication experiments to strengthen this study. 
Previous studies have demonstrated that Cpn can establish a persistent infection 
within monocytes and lead to chronic inflammation (43). It has been proposed that 
monocytes can travel to distant anatomical sites, cross the blood brain barrier and 
produce neuroinflammation. This neuroinflammation leads to the neurodegeneration seen 
in LOAD ( 42). Therefore, an understanding of the evolution of acute to persistent Cpn 
infection within monocytes is crucial to our understanding of disease pathogenesis of 
LOAD. 
Cpn gene expression within monocytes is still not well understood. Although 
genome wide transcriptional analyses have been studied within epithelial cell lines, 
monocytes are an important part of disease pathogenesis. Our study aids in this 
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understanding, however there is much to still be elucidated within this field. Continued 
research evaluating Cpn gene expression following infection of monocytes is crucial to 
understanding the evolution of acute to persistent infection. Genetic profiling of Cpn will 
help us better identify transcriptional patterns that are consistent with persistent Cpn 
infections. In addition, a better understanding of gene expression and regulation could 
potentially lead to treatments that could aid in eradicating persistent infections prior to 
them leading to disease pathology. 
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APPENDIX 
5.1 Additional Material and Methods: DNA Isolation 
DNA was purified according to the manufacturer's instructions using a DNeasy 
isolation kit (Qiagen DNeasy). Frozen pellets were thawed and centrifuged for 5 min at 
300 x g. Pellets contained lx106 cells was for each sample. 150 µL of PBS, 20 µL of 
proteinase K, and 200 µL of Buffer AL was added to sample and vortexed thoroughly 
followed by incubation in a water bath for 10 min at 56 "C. After incubation, 200 µL of 
ethanol was added to each sample and vortexed to yield a homogeneous solution. The 
entire mixture was then pipetted into a DNeasy Mini spin column placed in a 2mL 
collection tube. Each sample was centrifuged for I min at 6000xg. The flow through and 
collection tube was discarded and the DNeasy spin column was placed in new collection 
tube. 500ul of Buffer AWi was added to the spin column and centrifuged for 1 min at 
6000xg. Flow through and collection tube were discarded and the DNeasy spin column 
was placed in new collection tube. 500ul of Buffer AW2 was added to the spin column 
and centrifuged for 3 min at 20,000xg to dry the DNeasy membrane. Flow through and 
collection tube were discarded and DNeasy spin colmnn was placed in new collection 
tube. Sample was centrifuged again for 1 min at 20,000xg to ensure all ethanol was 
evaporated from spin column. Flow through and collection tube were discarded and the 
DNeasy spin column was placed in a 2ml microcentrifuge tube. lOOul of Buffer AE was 
pipetted into the column and centrifuged for 1 min at 6000xg. This step was repeated for 
a total of 200ul of eluted DNA in Buffer AE. Samples were frozen and stored at -60°C 
until DNA was used for RT-PCR. 
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After DNA isolation was performed, overall DNA yield was determined by using 
UV Spectrophotometry. Other measurements recorded included purity values: 
40 
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5.3 Additional Results 
5.3.1 abcX qRT-PCR raw data 
AR39 RQvalue at RQ value at RQ value at RQ value at RQ value at 
24 hpi 48 hpi 72 hpi 96 hpi 120 hpi 
Plate 2.61 1.00 0.47 1.03 *** 
022415 
Plate 3.24 1.00 1.08 0.42 0.63 
031615 
Mean 2.93 1.00 0.78 0.73 NIA 
SD 0.45 0.00 0.43 0.43 NIA 
Table 3 
CWL029 RQ value at RQvalue at RQ value at RQvalue at RQ value at 
. .. 24 hpi 48 hpi 72 hpi 96 hpi 120 hpi 
Plate 1.41 1.00 0.45 0.33 0.42 
030915 
Plate 0.78 1.00 3.09 1.07 0.69 
031615 
Mean 1.10 1.00 1.77 0.70 0.56 
SD 0.45 0.00 1.87 0.52 0.19 
Table4 
Table 3 and 4. Results of abcX gene expression following infection of THP 1 Human 
Monocytes with two different Cpn strains AR39 and CWL029. Cells were infected 
separately (MOI 1) with Cpn. Cells were lysed and RNA was extracted at 24, 48, 72, 96, 
and 120 hpi. 48 hpi was used as a reference time point and J 8S was used as a chlamydia! 
housekeeping gene to normalize transcription levels. Relative quantity (RQ) refers to the 
gene expression level after RT-PCR (Real Time PCR). Individual experiments were 
performed with 3 technical replicates. * * * represents gene targets that did not amplify 
and therefore no RQ values were obtained. 
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5.3.2 euo qRT-PCR raw data 
·. AR39 RQ value at RQvalueat RQ value at RQ value at RQ value at 
. 24 hpi 48 hpi 72 hpi 96 hpi 120 hpi 
Plate 4.44 1.00 1.47 0.35 1.35 
021815 
Plate 6.43 1.00 4.73 2.78 2.96 
031815 
Mean 5.44 1.00 3.10 1.57 2.16 
SD 1.41 0.00 2.31 1.72 1.14 
Table 5 
CWL029. RQ value at RQ value at RQ value at RQ value at RQ value at 
· .. 24 hpi 48 hpi 72 hpi 96 hpi 120 hpi 
Plate 0.75 1.00 1.08 2.35 2.01 
031115 
Plate 0.74 1.00 *** 1.11 0.28 
031815 
Mean 0.75 1.00 NIA 1.73 1.15 
SD 0.01 0.00 NIA 0.88 1.22 
Table 6 
Table 5 and 6. Results of euo gene expression following infection of THP 1 Human 
Monocytes with two different Cpn strains AR39 and CWL029. Cells were infected 
separately (MOI I) with Cpn. Cells were lysed and RNA was extracted at 24, 48, 72, 96, 
and 120 hpi. 48 hpi was used as a reference time point and I BS was used as a chlamydia! 
housekeeping gene to normalize transcription levels. Relative quantity (RQ) refers to the 
gene expression level after RT-PCR (Real Time PCR). Individual experiments were 
performed with 3 technical replicates. *** represents gene targets that did not amplify 
and therefore no RQ values were obtained. 
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5.3.3 129 qRT-PCR raw data 
AR39. RQ value at RQ value at RQ value at RQ value at RQ value at 
.. 
24hpi 48 hpi 72 hpi 96 hpi 120 hpi 
Plate 1.79 I.DO 1.26 0.19 0.46 
Plate 0.64 1.00 0.9 0.16 *** 
031815 
Mean 1.22 1.00 1.08 0.18 NIA 
SD 0.81 0.00 0.25 0.02 NIA 
Table 7 
·cwto29· RQ value at RQ value at RQ value at RQ value at RQ value at 
.. · .· 24 hpi 48 hni 72 hni 96hni 120 hni 
Plate 0.59 I.DO 1.21 1.03 0.82 
031115 
Plate 2.19 1.00 *** 0.55 0.36 
031815 
Mean 1.39 I.DO NIA 0.79 0.59 
SD 1.13 0.00 NIA 0.34 0.33 
Table 8 
Table 7 and 8. Results of 129 gene expression following infection of THP 1 Human 
Monocytes with two different Cpn strains AR39 and CWL029. Cells were infected 
separately (MOI I) with Cpn. Cells were lysed and RNA was extracted at 24, 48, 72, 96, 
and 120 hpi. 48 hpi was used as a reference time point and I BS was used as a chlamydia! 
housekeeping gene to normalize transcription levels. Relative quantity (RQ) refers to the 
gene expression level after RT-PCR (Real Time PCR). Individual experiments were 
performed with 3 technical replicates. *** represents gene targets that did not amplify 
and therefore no RQ values were obtained. 
